Myasthenia Gravis

Care Standards for Myasthenia Gravis

The Myasthenia Gravis Foundation of America has created this Healthcare professional resource. It is a very complete document that outlines the conditions epidemiology, diagnosis, and management. Highlighting the issues that people with this condition may experience as well as the drugs that need to be avoided. 

MGimage.PNG
  • Physician Issues

  • Nursing Issues

  • Anesthesia Issues

  • Emergency Care Issues

  • Psychosocial Issues: From diagnosis to Lifetime Management

  • Physical Therapy Issues

  • Occupational Therapy Issues

  • Speech Pathology and Swallowing Issues

  • Dental Care Issues

  • Guidelines for the Pharmacist. 

Click the image to view the full document

 

Medications to avoid: Important Statement

Many different drugs have been associated with worsening myasthenia gravis (MG). However, these drug associations do not necessarily mean that a patient with MG should not be prescribed these medications because in many instances the reports are very rare and in some instances they might only be a "chance" association (i.e. not causal). Also some of these drugs may be necessary for a patient's treatment. Therefore, some of these drugs should not necessarily be considered "off limits" for MG patients. Careful thought needs to go into decisions about prescription. It is advisable that patients and physicians recognize and discuss the possibility that a particular drug might worsen the patient's MG. They should also consider, when appropriate, the pros and cons of an alternate treatment, if available. It is important that the patient notify their physician if the symptoms of MG worsen after starting any new medication. We are only listing the more common prescription drugs with the strongest evidence suggesting an association with worsening MG.  Read more here.


Would you like someone from MDA to speak to you and your colleagues or students or at your conferences?

Email  info@mda.org.nz